The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

One reason why our livers excel at clearing waste from our blood system is that the organ functions according to three key ...

Eli Lilly and Company, which already markets weight-loss and diabetes drugs that must be injected, is a step closer to introducing a once-daily pill for the same conditions. On April 17 ...

AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process. As pharmaceutical companies focus increasingly on the development of ...

The Trump administration has taken its next steps toward imposing more tariffs on key imports, launching investigations into ...

Bakker believes that this is where non-profits can step in to provide the “time ... by having the right individuals with disease and drug development expertise, and the necessary focus to ...